Skip to content
← Full study record

NCT00301834 · MORE INFO

Limitations, agreements, and source contact

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders · Source last updated 2017-09-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mcowan@peds.ucsf.edu
organization
University of California San Francisco
phone
4154762188
title
Dr. Morton Cowan
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mcowan@peds.ucsf.edu
organization
University of California San Francisco
phone
4154762188
title
Dr. Morton Cowan

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice